Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 18.15
+0.15 (0.83%)
At close: Jul 10, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 103.5 million as of July 10, 2026. Its market cap has decreased by -10.32% in one year.
Market Cap
103.50M
Enterprise Value
248.85M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
18.15
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 103.50M, a decrease of -56.96%. That is a compound annual growth rate of -17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 103.50M | -27.35% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.58B |
| Basilea Pharmaceutica AG | 678.05M |
| Newron Pharmaceuticals | 245.51M |
| Santhera Pharmaceuticals Holding AG | 227.94M |
| BioVersys AG | 161.00M |
| Molecular Partners AG | 121.16M |
| MindMaze Therapeutics Holding | 26.52M |